Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rosalba Miceli

Showing results (81-90 of 226) with videos related to

Pageof 23
Sort By:
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 14, 2022
Treatment strategies and outcomes of primary Myxofibrosarcomas in a large patients cohortStefano Radaelli, Sandro Pasquali, Chiara Colombo, et al.
Tumori|May 2, 2018
Prognostic role of PIK3CA and TP53 in human papillomavirus-negative oropharyngeal cancersCarlo Resteghini, Federica Perrone, Rosalba Miceli, et al.
Head & Neck|November 18, 2018
Impact of treatment expertise on the outcome of patients with head and neck cancer treated within 6 randomized trialsPaolo Bossi, Rosalba Miceli, Marco Benasso, et al.
Cancer|July 29, 2010
Pretransplantation [18-F]fluorodeoxyglucose positron emission tomography scan predicts outcome in patients with recurrent Hodgkin lymphoma or aggressive non-Hodgkin lymphoma undergoing reduced-intensity conditioning followed by allogeneic stem cell transplantationAnna Dodero, Roberto Crocchiolo, Francesca Patriarca, et al.
Breast (Edinburgh, Scotland)|September 3, 2025
Denosumab versus zoledronic acid in metastatic breast cancer: A retrospective observational analysis of 24-dose regimens on analgesia and skeletal-related event preventionGiacomo Massa, Noemi Simeone, Gabriele Tinè, et al.
Annals of Surgical Oncology|November 11, 2020
A Prospective Observational Study of Multivisceral Resection for Retroperitoneal Sarcoma: Clinical and Patient-Reported Outcomes 1 Year After SurgeryMarco Fiore, Cinzia Brunelli, Rosalba Miceli, et al.
International Journal of Molecular Sciences|July 27, 2022
Potential of the Stromal Matricellular Protein Periostin as a Biomarker to Improve Risk Assessment in Prostate CancerValentina Doldi, Mara Lecchi, Silva Ljevar, et al.
Head & Neck|January 1, 2005
Which classification for ethmoid malignant tumors involving the anterior skull base?Giulio Cantù, Carlo L Solero, Rosalba Miceli, et al.
Annals of Surgical Oncology|April 16, 2010
Aggressive surgery in retroperitoneal soft tissue sarcoma carried out at high-volume centers is safe and is associated with improved local controlSylvie Bonvalot, Rosalba Miceli, Mattia Berselli, et al.
Cancers|September 27, 2014
Circulating biomarkers in advanced colorectal cancer patients randomly assigned to three bevacizumab-based regimensAntonia Martinetti, Rosalba Miceli, Elisa Sottotetti, et al.
Pageof 23

Showing results (81-90 of 226) with videos related to

Sort By:
Pageof 23
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 14, 2022
Treatment strategies and outcomes of primary Myxofibrosarcomas in a large patients cohortStefano Radaelli, Sandro Pasquali, Chiara Colombo, et al.
Tumori|May 2, 2018
Prognostic role of PIK3CA and TP53 in human papillomavirus-negative oropharyngeal cancersCarlo Resteghini, Federica Perrone, Rosalba Miceli, et al.
Head & Neck|November 18, 2018
Impact of treatment expertise on the outcome of patients with head and neck cancer treated within 6 randomized trialsPaolo Bossi, Rosalba Miceli, Marco Benasso, et al.
Cancer|July 29, 2010
Pretransplantation [18-F]fluorodeoxyglucose positron emission tomography scan predicts outcome in patients with recurrent Hodgkin lymphoma or aggressive non-Hodgkin lymphoma undergoing reduced-intensity conditioning followed by allogeneic stem cell transplantationAnna Dodero, Roberto Crocchiolo, Francesca Patriarca, et al.
Breast (Edinburgh, Scotland)|September 3, 2025
Denosumab versus zoledronic acid in metastatic breast cancer: A retrospective observational analysis of 24-dose regimens on analgesia and skeletal-related event preventionGiacomo Massa, Noemi Simeone, Gabriele Tinè, et al.
Annals of Surgical Oncology|November 11, 2020
A Prospective Observational Study of Multivisceral Resection for Retroperitoneal Sarcoma: Clinical and Patient-Reported Outcomes 1 Year After SurgeryMarco Fiore, Cinzia Brunelli, Rosalba Miceli, et al.
International Journal of Molecular Sciences|July 27, 2022
Potential of the Stromal Matricellular Protein Periostin as a Biomarker to Improve Risk Assessment in Prostate CancerValentina Doldi, Mara Lecchi, Silva Ljevar, et al.
Head & Neck|January 1, 2005
Which classification for ethmoid malignant tumors involving the anterior skull base?Giulio Cantù, Carlo L Solero, Rosalba Miceli, et al.
Annals of Surgical Oncology|April 16, 2010
Aggressive surgery in retroperitoneal soft tissue sarcoma carried out at high-volume centers is safe and is associated with improved local controlSylvie Bonvalot, Rosalba Miceli, Mattia Berselli, et al.
Cancers|September 27, 2014
Circulating biomarkers in advanced colorectal cancer patients randomly assigned to three bevacizumab-based regimensAntonia Martinetti, Rosalba Miceli, Elisa Sottotetti, et al.
Pageof 23